Friday, January 31, 2020

SAMI-SABINSA GROUP -NEW MANUFACTURING FACILITY IN HASSAN.


About Sami-Sabinsa Group:
An  Indian MNC is in the domain of Health Science
and Nutraceuticals was founded in 1988 by Dr.Muhammed Majeed.
The Company has 242 US & International patents & has 290 
pending patents applications worldwide.The Company has
operations in 14 countries & has a turnover of Rs.850 crores(approx)
in domestic operations.

Sami- Sabinsa Group is setting up New Manufacturing facility
at Pharma SEZ Industrial area,Hassan in Karnataka.The first
phase of the plant will house a 40,000 Sq.Mtrs world class 
Nutraceuticals ingredients (ANI ) manufacturing unit with an
annual capacity of 300 tons & will be functional by 2021.The
new facility will have an investment of Rs.200 crores.

Addressing media,Dr.Muhammed Majeed,Founder & Chairman,
Sami-sabinsa Group said," we are committed to a research oriented
science based approach towards developing products that makes life
healthier & better.". 


Tuesday, January 28, 2020

FANS WITH ART- FANZART- DESIGNER FANS.

FANZART SETS A BENCH MARK FOR DESIGNER FANS.

The Brain Child of Anil Lala,is the leader in creating fancy designer
 fans suiting every need & every decor.Fanzart's Tag line  is
"Designer Fans for Designer Homes". As a product driven company,
Fanzart has over 80 designer Models & has presence internationally.
The Company has flagship store at 100 feet Road,Indiranagar,Bangalore.

To quote Anil Lala,Founder,"At Fanzart,we believe that beauty & Technology
together can bring about evolutionary innovation.We also believe that,
it is only with a great quality product that the customer truly embraces 
with innovation".

Fanzart has 55 Brick & Mortar experience centres in the country & also
has significant On line presence.

Friday, January 24, 2020

TATA MOTORS LAUNCH ALTROZ -GOLD STANDARD IN SAFETY.

Tata Motors launched Premium hatchback -The ALTROZ
The  Altroz is the first vehicle developed on the new ALFA
architecture.With its striking design,bouquet of industry 
Mr.Jaideep Gupte,Regional Manager, &
Mr.Vivek Srivatsa,Head-Marketing -
Tata Motors
first features and the recent achivement of Global NCAP 
5 star rating, it has set the GOLD standard in safety,Design, 
Driving dynamics,Technology and Customer Delight.The
Altroz comes in 6 different factory fitted customizable options.Altroz is Industry's first
fully BS VI ready Diesel Hatchback.



" We are confident that the ALTROZ will not only deliver

the best driving experience to our customers,but also set
new benchmarks as we set foot into the premium hatchback
segment"says Mr.Vivek Srivatsa,Head-Marketing,Passenger
Vehicle Business Unit,Tata Motors.

To know about the new range or to book a test drive,customers
can visit 'cars.tatamotors.com' or follow social handles across
Twitter-https://twitter.com/t\TataMotors_Cars and facebook
https://www.facebook.com/officialtatamotors.
'

Monday, January 20, 2020

RANITIDINE NOT BANNED -AN AGE OLD MEDICINE TO TREAT GASTRIC ACIDITY.

A group of Prominent Doctors in Bengaluru met the media
& clarified that Ranitidine,an age old medicine to treat
gastric acidity is not banned.They said there is lot of 
misconception & unnecessary confusion regarding
Ranitidine.

Earlier, there was a news item stating that Drug Controller
General of India (DGCI) had advised the manufacturers of
Ranitidine to verify their products and take appropriate
measures to ensure patient safety.

FACTS ON RANITIDINE:
1.Neither USFDA nor DGCI has asked for ban on Ranitidine.
2.Features in WHO's list of Essential Medicines.

The USFDA tested   numerous Ranitidine products & found 
levels of NDMA similar to levels one would be exposed to if 
they ate common foods like grilled Or Smoked meats.
Dr.T.R.Raghu,HOD,Cardiology,Jayadeva Institute of Cardio
Vascular & Sciences & Research said,"The USFDA,in its 
statement,confirmed that Ranitidine does not lead to Cancer
in typical stomach conditions of humans.Cardiologists like me
have been prescribing Ranitidine for several years & haven't yet
come across any adverse reactions in patients"
Ranitidine is given to outdoor  patients as well as the patients in
ICU when they ar dealing with stress Ulcers says,Dr.Ashok Kumar,
Professor & HOD,Jayadeva Institute.

Dr,Nagendra Kumar,Columbia Hospitals,Dr.Purushotham Chavan,
Kidwai Memorial Institute of Oncology & Dr.Arun K.N.,Nephrologist
Bhagween Jain Hospital also addressed the media.

CPRI CELEBRATES DIAMOND JUBILEE WITH INSTITUTE DAY .

Mr.V.S.Nandakumar,Director General.CPRI welcoming
Prof.G.D.Yadav,Chief Guest.
Central Power Research Institute (CPRI),an autonomous
body under Minisytry of Power,Government of India, 
celebrates Diamond Jubilee with the Institute Day.To 
Mark the occassion,Jawaharlal Nehru Memorial Lecture
was arranged.The Theme of the Lecture was" The Global
Energy Scenario & Hydrogen Economy".The lecture was
delivered by Prof.G.D.Yadav, Padmashri,& Professor
Emeritus,Institute of Chemical Technology,Mumbai.

CPRI-Diamond Jubilee Special Postal Cover was 
released byDr.Charles Lobo,IPoS,Chief Post Master 
General,Karnataka Circle.CPRI, undertakes R&D Activities 
& is the nodal agency for funding research schemes in the Power 
Generation,Transmission & Distribution of electricity.CPRI 
is the recognised certifying agency for electrical equipment for 
energy efficient operation in accordance with the standards 
and labelling programme of Bureau of Energy Efficiency.

TARUN LALA THE CO OWNER OF SOUTHSIDE WARRIORS -A 7 MEMBER TEAM IN THE STREET BALL LEAGUE.


Tarun Lala.

ABOUT TARUN LALA: He is the Co-Founder of Fanzart,
and Founder of LevoLabz.He is B.S in Electrical Engineering
from the Northeastern University & Stanford GSB- Global
Innovations Ignite Programme in Entrepreneurship.He has 
the credit of introducing designer fans in India.

He is the proud Co Owner of Southside Warriors,a 7 member 
team in the Street Ball League, a first of its kind 3 on 3 
Basketball Tournament.This was conceptualised &initiated by Ranvijay Singha & Harman Singha,brothers.
Tarun Lala said,that the team has sponsors like Amaron,Gamepoint & Apollo on board.

Sunday, January 12, 2020

REORGANISATION & INDEPENDENT SAFETY REGULATOR FOR RAILWAYS.

Reorganisation & setting up an Independent  Safety Regulator
is the need of the hour for Indian Railways.Even Niti Ayog,the 
Policy think Tank has also suggested the same.Even the Kakodkar
panel has also recommended the same.The Ministry of Railways
should take up immediately .May be, the Railways have problems 
of finance.They must think of out of the Box solutions as they 
have huge assets.Rakesh Mohan Committee to Bibek Debroy
committee has recommnded for reorganisation of Railways into 
separate companies which can compete with each other.Konkan
Railway Corporation is an ideal case to emulate as they have
achieved a net profit of Rs.102 crores for 2018-19.